GlobeNewsWire
28 Sept 2026, 12:45 UTC · 7w ago
Lifecore Biomedical to be Acquired by Webster Equity Partners
Impact · against what's priced in
LFCR is being acquired by Webster Equity Partners for $6.28 per share in cash, representing a 49.5% premium over its recent close. Total potential value reaches $9.67 per share if $160 million in CVR milestones are met, providing a significant immediate floor and substantial upside.
- LFCR+1.00
No priced-in read yet
- In context
The definitive agreement to be acquired at $6.28 per share cash plus CVRs creates an immediate valuation floor and a potential total payout of $9.67 per share.
Read from the article alone





